China — Coffee and Tea

← back to leaderboard

China received 24 FDA import refusals in Coffee and Tea between 2023-Q4 and 2026-Q3. Volume peaked at 10 in 2025-Q4, with the trend rising sharply year-on-year. The most-cited issues are inadprcctl, lacks n/c, and needs fce. No trade baseline is published for this commodity from China, so no per-$1B rate is shown here.

Of these, 6 were hazard refusals and 18 were paperwork refusals.

Exporting from China? Get an email when shipments from China are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

1 2023-Q4 2023-Q4: 1 1 2024-Q1 2024-Q1: 1 0 2024-Q2 2024-Q2: 0 0 2024-Q3 2024-Q3: 0 6 2024-Q4 2024-Q4: 6 1 2025-Q1 2025-Q1: 1 0 2025-Q2 2025-Q2: 0 1 2025-Q3 2025-Q3: 1 10 2025-Q4 2025-Q4: 10 1 2026-Q1 2026-Q1: 1 1 2026-Q2 2026-Q2: 1 2 2026-Q3 2026-Q3: 2

Recent rejections